Previous 10 | Next 10 |
After jumping as much as 282% from Thursday's closing price to the high yesterday, Sorrento Therapeutics (NASDAQ: SRNE) dropped 16.6% on Tuesday on no apparent news -- other than, of course, that the biotech had jumped a 282% in less than two trading days, followed by a dose of reality as it...
Gainers: Nano Dimension NNDM +272% . More news on: ShiftPixy, Inc., Mercurity Fintech Holding Inc., Iterum Therapeutics plc, Stocks on the move, , Read more ...
May 19, 2020 Palm Beach, FL – May 19, 2020 – The global science community is arguably facing one of its greatest challenges yet in the current global healthcare crisis. Article after article demonstrates that the global pandemic is causing the breakdown of soci...
You know a company has some really good news when its stock skyrockets 144% in a single day . That's exactly what Sorrento Therapeutics (NASDAQ: SRNE) shares did on Friday. And it looked like the biotech's momentum would keep going on Monday, with Sorrento soaring more than 40% early b...
( Pexels ) Next to technology, healthcare has been the top-performing sector so far this year. Equities in the sector saw moderate declines during the March crash as investors discount higher revenue for many firms. Since the market's March lows, the Health Care Select Sect SPDR ETF's ( XLV ...
Sorrento Therapeutics (NASDAQ: SRNE) , a clinical-stage biotech, is off to a strong start this week. The drugmaker's shares are up by a healthy 42.6% in pre-market trading Monday morning. Last Friday, Sorrento's shares gained an astounding 158% in response to the company's announceme...
Sorrento Therapeutics (NASDAQ: SRNE ) +36% in reaction to reports that it has discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc., Moderna, Inc., Fulgent Genetics, Inc., Stocks on the ...
Vital Knowledge Media joined Stat's Adam Feuerstein in voicing skepticism over Friday's announcement that Sorrento Therapeutics (NASDAQ: SRNE ) had discovered an antibody, dubbed STI-1499, that, it says, can provide 100% inhibition of COVID-19. More news on: Sorrento Therapeutics, Inc....
Introduction Sorrento Therapeutics ( SRNE ) closed up 158% on news of a member of Sorrento’s proprietary G-MAB antibody library, STI-1499, demonstrating 100% in-vitro inhibition of Sars-CoV-2, the virus responsible for the global COVID-19 pandemic. Data by YCharts The result...
Image: My great-grandfather (second from left) and his buddies in the 88th Division of the United States Army during World War I, at the time of the Spanish flu pandemic of 1918-1919. He would serve under Major General William Weigel, become proficient in the 37mm gun, and take part in the...
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
Fuse Medical Inc (FZMD) is expected to report for Q1 2024 PhoneX Holdings Inc (PXHI) is expected to report for Q1 2024 Avalon GloboCare Corp. (ALBT) is expected to report for Q1 2024 Ricoh Company Ltd ADR (RICOY) is expected to report for Q4 2024 Amplitech Group Inc. (AMPG) is exp...
Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...
Sorrento Therapeutics Inc. (SRNE) is expected to report for Q1 2023